Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Disorders of Hemostasis01:24

Disorders of Hemostasis

737
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
737
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

3
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
3
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

3
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
3
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

633
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
633
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

123
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
123
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

6.1K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
6.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Atypical cardiac melioidosis masquerading as a right atrial mass: a case report.

Indian journal of thoracic and cardiovascular surgery·2026
Same author

Rare Right Lung Tumor with Intracardiac Extension: A Case of Successful Multidisciplinary Management.

Annals of cardiac anaesthesia·2026
Same author

Effect of preoperative oral iron supplementation on postoperative outcomes in children with acyanotic congenital heart disease undergoing cardiac surgery: a pragmatic randomised clinical trial.

Cardiology in the young·2026
Same author

Splenic artery aneurysm and infarction during pregnancy from infective endocarditis.

BMJ case reports·2024
Same author

Pyuria in hospitalized general medical patients without urinary tract infection.

F1000Research·2024
Same author

Evaluation of Postoperative Pain After Cardiothoracic Surgery in Patients With and Without Significant Preoperative Anxiety: A Prospective Observational Study.

Annals of cardiac anaesthesia·2024

Related Experiment Video

Updated: Jun 11, 2025

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

83.5K

Clinical predictors of warfarin-associated bleeding: A case-control study.

Shahanaze Javath Hussain1, Surendran Deepanjali2, Hemachandren Munuswamy3

  • 1Senior Resident, Department of Medicine, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India.

Tropical Doctor
|October 10, 2024
PubMed
Summary

Warfarin bleeding risk factors differ in diverse populations. Decreased food intake, older age, and prior bleeding predict warfarin-related bleeding events, necessitating closer monitoring.

Keywords:
AnticoagulantsHAS-BLED scorebleedingtime in therapeutic rangewarfarin

More Related Videos

Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice
08:13

Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice

Published on: September 30, 2021

6.1K
Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
13:08

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay

Published on: September 9, 2012

18.9K

Related Experiment Videos

Last Updated: Jun 11, 2025

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

83.5K
Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice
08:13

Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice

Published on: September 30, 2021

6.1K
Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
13:08

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay

Published on: September 9, 2012

18.9K

Area of Science:

  • Internal Medicine
  • Pharmacology
  • Clinical Research

Background:

  • Warfarin remains crucial in resource-limited settings for anticoagulation.
  • Bleeding due to warfarin overdosage is a significant clinical concern.
  • Risk factors for warfarin-induced bleeding may vary across patient demographics.

Purpose of the Study:

  • To identify independent predictors of bleeding in adult patients prescribed warfarin.
  • To evaluate the utility of the HAS-BLED score in predicting warfarin-related bleeding events.

Main Methods:

  • A case-control study design was employed.
  • Cases were adults on warfarin presenting with bleeding; controls were on warfarin without bleeding.
  • The HAS-BLED score was calculated for all participants.

Main Results:

  • Decreased food intake was strongly associated with bleeding events.
  • Independent predictors of bleeding included older age, higher warfarin doses, recent illness, and prior bleeding history.
  • The HAS-BLED score did not independently predict bleeding in this cohort.

Conclusions:

  • Specific factors like reduced food intake and recent illness require attention for warfarin safety.
  • Enhanced monitoring of international normalized ratio (INR) is recommended during acute illnesses and in patients with decreased food intake.
  • Clinical practice should adapt warfarin management based on identified patient-specific risk factors.